GLYCOPYRROLATE INJECTION USP
JAMP PHARMA CORPORATION
Quick answers
Is there a shortage of GLYCOPYRROLATE INJECTION USP in Canada?
No. There is no current shortage of GLYCOPYRROLATE INJECTION USP 0.2MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
GLYCOPYRROLATE INJECTION USP
SANDOZ CANADA INCORPORATED
GLYCOPYRROLATE INJECTION MULTIDOSE
OMEGA LABORATORIES LIMITED
Other Products
ROBINUL 0.2MG/ML LIQ INJ
WYETH-AYERST CANADA INC.
CUVPOSA
MEDEXUS PHARMACEUTICALS INC.
ROBINUL FORTE TAB 2MG
AYERST LABORATORIES
ROBINUL-FORTE TAB 2MG
WYETH-AYERST CANADA INC.
DIN
02532379
Strength
0.2MG
Dosage Form
Solution
Route
Intravenous Intramuscular
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from JAMP PHARMA CORPORATION
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
225MG · DIN 02420694
250MG · DIN 02529459
50MG · DIN 02423227
2.5MG · DIN 02492199
10MG · DIN 02429225
5MG · DIN 02429217
DIN 02532174
DIN 02532182
500MG · DIN 02523825
2MG · DIN 02553341
100MG · DIN 02509172
25MG · DIN 02509164